519 related articles for article (PubMed ID: 28320106)
1. CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway.
Cheng C; Yu S; Kong R; Yuan Q; Ma Y; Yang W; Cao G; Xie L
Biomed Pharmacother; 2017 May; 89():1387-1391. PubMed ID: 28320106
[TBL] [Abstract][Full Text] [Related]
2. Glaucocalyxin A Attenuates the Activation of Hepatic Stellate Cells Through the TGF-β1/Smad Signaling Pathway.
Dong Z; Gao Q; Guo H
DNA Cell Biol; 2018 Mar; 37(3):227-232. PubMed ID: 29327938
[TBL] [Abstract][Full Text] [Related]
3. Scoparone attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway.
Liu X; Zhao X
Biomed Pharmacother; 2017 Sep; 93():57-61. PubMed ID: 28623783
[TBL] [Abstract][Full Text] [Related]
4. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
5. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
[TBL] [Abstract][Full Text] [Related]
6. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of eIF3a attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):107-11. PubMed ID: 27262813
[TBL] [Abstract][Full Text] [Related]
8. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
9. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
10. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
11. C1q/tumor necrosis factor-related protein-3 acts as a target treating hepatic fibrosis.
Sun BR; Li HY; Wang GP; Jia QA; Zhang C
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5374-5382. PubMed ID: 34533812
[TBL] [Abstract][Full Text] [Related]
12. (Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway.
Hsieh YC; Lee KC; Lei HJ; Lan KH; Huo TI; Lin YT; Chan CC; Schnabl B; Huang YH; Hou MC; Lin HC
Cell Mol Gastroenterol Hepatol; 2021; 12(3):813-838. PubMed ID: 34087453
[TBL] [Abstract][Full Text] [Related]
13. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
15. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
17. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
19. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway.
Fang L; Huang C; Meng X; Wu B; Ma T; Liu X; Zhu Q; Zhan S; Li J
Toxicol Appl Pharmacol; 2014 Oct; 280(2):335-44. PubMed ID: 25150141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]